Pharmesis International Ltd. (SGX:BFK)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.4550
0.00 (0.00%)
Last updated: Sep 24, 2025, 9:00 AM SGT
329.25%
Market Cap 14.42M
Revenue (ttm) 12.62M
Net Income (ttm) 1.85M
Shares Out 31.70M
EPS (ttm) 0.06
PE Ratio 7.82
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 5,670
Open 0.4550
Previous Close 0.4550
Day's Range 0.4550 - 0.4550
52-Week Range 0.1000 - 0.7000
Beta -0.92
RSI 43.30
Earnings Date Nov 10, 2025

About Pharmesis International

Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China. The company provides prescribed products and over-the-counter drugs. It offers western medicine products under the Kinna brand, including Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Compound Procaine hydrochloride to treat arterioscler... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 1,096
Stock Exchange Singapore Exchange
Ticker Symbol BFK
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.